PBH — Prestige Consumer Healthcare Inc.
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 1295947 ·
Last close
$46.61
Market Cap
$2.21B
52W High
$71.07
52W Low
$42.62
ADV30
535,383
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 265,710,000 | 136,188,000 | 52,520,000 | 29,177,000 | 4,568,573,000 | 89,127,000 | 2,651,857,000 |
| Mar 2026 | 281,617,000 | 146,299,000 | 75,492,000 | 53,928,000 | 3,494,313,000 | 63,868,000 | 1,606,797,000 |
| Dec 2025 | 283,444,000 | 157,369,000 | 82,491,000 | 46,696,000 | 3,494,743,000 | 62,373,000 | 1,665,292,000 |
| Sep 2025 | 274,114,000 | 151,579,000 | 79,670,000 | 42,211,000 | 3,442,280,000 | 119,106,000 | 1,617,311,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$249,402,000
Investing CF
$-1,198,640,000
Financing CF
$898,674,000
CapEx
$-14,043,000
Dividends Paid
—
Buybacks
$-121,508,000
EPS Diluted TTM
$3.57
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$1,775,280,000
Inventory
$190,215,000
Receivables
$187,355,000
ST Investments
—
EBIT TTM
$280,341,000
Pretax Income TTM
$234,260,000
Interest Exp TTM
$46,081,000
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,104,884,992
EBITDA
$325,372,992
Free Cash Flow
$147,887,504
Enterprise Value
$4,202,544,896
Total Cash
$89,127,000
Total Debt
$2,067,437,952
Shares Out
47,374,522
Trailing EPS
$3.57
Book Value
$40.46
ROE
9.1%
ROA
4.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 1,088,705,000 | 309,409,000 | 190,301,000 | 3,494,313,000 | 1,606,797,000 | 1,887,516,000 | 257,627,000 |
| Mar 2025 | 1,137,762,000 | 349,241,000 | 214,605,000 | 3,402,218,000 | 1,567,321,000 | 1,834,897,000 | 251,515,000 |
| Mar 2024 | 1,125,357,000 | 342,429,000 | 209,339,000 | 3,318,417,000 | 1,663,333,000 | 1,655,084,000 | 248,926,000 |
| Mar 2023 | 1,127,725,000 | 347,802,000 | -82,306,000 | 3,353,729,000 | 1,906,645,000 | 1,447,084,000 | 229,716,000 |
TTM Snapshot
Revenues TTM
$1,123,052,000
NetIncome TTM
$216,244,000
OpCashFlow TTM
$0
Assets (Latest)
$3,402,218,000
Forward EPS
$5.08
Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $50.00 · spot: $47.08 · call volume: 65 · put volume: 39
Expected Move to 2026-10-16:
±$14.55
(30.90%) —
implied range
$32.53 –
$61.63
· ATM straddle on $45.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc. | $2.19B | $16.44 | — |
| PHVS | Pharvaris N.V. | $2.25B | $32.02 | — |
| PRGO | PERRIGO Co plc | $2.13B | $15.42 | — |
| MLYS | Mineralys Therapeutics, Inc. | $2.29B | $25.86 | — |
| BHC | Bausch Health Companies Inc. | $2.13B | $5.69 | — |
News headlines (Yahoo Finance, 1h cache)
Prestige Consumer Healthcare Eyes Clear Eyes Recovery, $270M+ Free Cash Flow
2026-09-27 13:02 · Yahoo
PBH or NEOG: Which Is the Better Value Stock Right Now?
2026-09-14 15:40 · Yahoo
Prestige Consumer Healthcare Inc. to Participate in Barclays Global Consumer Conference
2026-09-08 21:00 · Yahoo
Is This the Right Time to Add PBH Stock to Your Portfolio?
2026-09-02 12:38 · Yahoo
PBH vs. SYK: Which Stock Is the Better Value Option?
2026-08-28 15:40 · Yahoo
Prestige Consumer Healthcare (PBH) Q1 2027 Earnings Call Transcript
2026-08-13 11:29 · Yahoo
PBH or SYK: Which Is the Better Value Stock Right Now?
2026-08-12 15:40 · Yahoo
Prestige Consumer Healthcare Inc. to Participate in Canaccord Genuity Annual Growth Conference
2026-08-10 21:00 · Yahoo
Prestige Consumer Healthcare Q1 Earnings Call Highlights
2026-08-09 00:03 · Yahoo
Prestige Consumer Healthcare Inc (PBH) (Q1 2027) Earnings Call Highlights: Record Cash Flow and ...
2026-08-06 23:17 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.